BIO insiders

25 insiders have filed at BIO since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Schwartz Alice N10% owner7.27M26.966%
Schwartz Norman DChairman & CEO4.88M18.095%
Schwartz Steven D10% owner401.9k1.491%1 sells $148k
Corey ColleenEVP, Global Human Resources19.6k0.073%
Dahowski DianeEVP, Global Supply Chain11.9k0.044%
Crowley MichaelEVP, Gbl Commercial Operations8.2k0.03%4 sells $2.0M
Last Andrew J.EVP, Chief Operating Officer7.6k0.028%1 sells $990k
Ernst Timothy SEVP, General Counsel & Sec3.4k0.013%5 sells $1.9M
May SimonEVP, President, Lsg3.1k0.012%
Daskal IlanEVP, Chief Financial Officer2.5k<0.01%
Evran SedatEVP, Global Supply Chain2.2k<0.01%
Lakkaraju Roop KalyanEVP, Chief Financial Officer1.8k<0.01%
Wright DaraEVP, President, Cdg1.8k<0.01%1 sells $359k
Allison SchwartzDirector1.5k<0.01%
Divincenzo Jonathan P.President & COO919<0.01%
Engelhardt Eva AnetteEVP, President, Cdg896<0.01%
Enloe Courtney CEVP, General Counsel & Sec629<0.01%
Barry JamesEVP, President, Lsg510<0.01%2 sells $420k
Ramalingam AjitSVP, Chief Accounting Officer403<0.01%
Pinkston Arnold ADirector308<0.01%
Pei Melinda LitherlandDirector308<0.01%
Hinckley Gregory KDirector308<0.01%
Edwards Jeffrey LDirector308<0.01%
Devilliers TaniaInt Prin Acctg Ofc55<0.01%
Mehta RajatEVP, Gbl Commercial Operations

Full register at boothcheck.com/insiders/BIO. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

BIO institutional holders · BIO research report